DC Biosciences Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

DC Biosciences General Information

Description

Operator of a biotechnology company intended to develop proteomics drugs. The company's technologies are placed to offer expertise in a wide range of bioscience disciplines including quantitative proteomics, chemical biology, biochemistry, bioinformatics, and cell biology, enabling researchers to enhance drug discovery initiatives and medical research.

Contact Information

Formerly Known As
Dundee Cell Products, Dunwilco (1342)
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • C/O Frp Advisory Trading Limited Apex 3
  • 95 Haymarket Terrace
  • Edinburgh EH12 5HD
  • Scotland, United Kingdom
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • C/O Frp Advisory Trading Limited Apex 3
  • 95 Haymarket Terrace
  • Edinburgh EH12 5HD
  • Scotland, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DC Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Out of Business 06-May-2024 Completed Out of Business
8. Grant 01-Apr-2016 Completed Generating Revenue
7. Later Stage VC 18-Jan-2013 Completed Generating Revenue
6. Grant 23-Nov-2011 Completed Generating Revenue
5. Early Stage VC 01-Jan-2009 Completed Generating Revenue
4. Grant 01-Sep-2007 Completed Generating Revenue
3. Seed Round 20-Apr-2007 Completed Generating Revenue
2. Grant $146K Completed Startup
1. Early Stage VC Completed Startup
To view DC Biosciences’s complete valuation and funding history, request access »

DC Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 3
Ordinary 2
Ordinary 1 3,700 $93.64 $93.64 1x $93.64 19.21%
To view DC Biosciences’s complete cap table history, request access »

DC Biosciences Patents

DC Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201103828-D0 Evaluation of therapeutic agent Inactive 07-Mar-2011
WO-2012120301-A1 Evaluation of therapeutic agent Inactive 07-Mar-2011

DC Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DC Biosciences FAQs

  • When was DC Biosciences founded?

    DC Biosciences was founded in 2006.

  • Where is DC Biosciences headquartered?

    DC Biosciences is headquartered in Edinburgh, United Kingdom.

  • What is the size of DC Biosciences?

    DC Biosciences has 2 total employees.

  • What industry is DC Biosciences in?

    DC Biosciences’s primary industry is Biotechnology.

  • Is DC Biosciences a private or public company?

    DC Biosciences is a Private company.

  • What is DC Biosciences’s current revenue?

    The current revenue for DC Biosciences is .

  • How much funding has DC Biosciences raised over time?

    DC Biosciences has raised $274K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process